| Serial Number | 85795273 |
| Word Mark | CLINIQAL |
| Filing Date | Wednesday, December 5, 2012 |
| Status | 710 - CANCELLED - SECTION 8 |
| Status Date | Friday, March 19, 2021 |
| Registration Number | 4586182 |
| Registration Date | Tuesday, August 12, 2014 |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Performance assessment services in the fields of medical devices, biotechnology and pharmaceuticals namely evaluation of the business efficiency and business management of clinical research and clinical and medical laboratories; business consultation services in the field of procedure and policy implementation, approval process and monitoring practices and procedures, all relating to the conduct of clinical trials in accordance with client and regulatory authority guidance, laws and expectations; assessment of the progress of clinical trials and compliance with study protocols, policies, procedures and regulatory requirements, namely, providing independent business review of clinical trials; evaluating business processes, procedures and policies in relation to clinical trials in the fields of medical devices, biotechnology and pharmaceuticals; audit services in the field of clinical trials, namely, assessment of regulatory requirements, business practices and management in the field of biotechnology, pharmaceutical and medical device in relation to Good Clinical Practice guidelines; audit services in the field of clinical, medical and bioanalytical laboratories, namely, assessment of business practices and management in relation to Good Clinical Laboratory Practice guidelines; clinical data management process assessments, namely, providing independent business review of database management; audit of clinical investigators and investigational plans, namely, business auditing of business processes and database management of clinical trials conducted by clients; systems audits, namely, business audits; clinical research gap analyses and needs assessment analyses, namely, review of clinical trials for business purposes; business consulting in the field of protocols, policies and procedures for customers specializing in clinical trials; preparation of audit plans and checklists, namely, development and implementation of business audit plans for others; assessment of compliance with protocols, processes and internal controls, namely, providing independent business review of business management and operations of clinical trials for business purposes; assessment of compliance to existing practice guidelines, namely, business auditing; preparation of audit reports, namely, gathering and reporting information obtained through audits conducted for business purposes; pre-clinical to phase four clinical trial consulting services, namely, business auditing; business consulting and management in the field of clinical trials, namely, clinical data management on behalf of medical device, biopharmaceutical and biotechnology companies to assist them with clinical research and applications for drug approval; business consulting and management for medical device, biotechnology and pharmaceutical companies, namely, business consultation and management of infrastructure development projects; providing independent review of clinical trials for business purposes in the fields of medical devices, biotechnology and pharmaceuticals |
| Goods and Services | Educational services, namely, conducting seminars and classes in the field of operations and administration of clinical trials and medical research in the field of medical devices, medicine and medical treatments; educational services, namely, conducting seminars and classes in the field of operations and administration of clinical, medical and bioanalytical laboratories; education services, namely, providing custom designed training seminars and workshops in the field of clinical trials, clinical laboratories, medical laboratories, and bioanalytical laboratories; training clinical trial site personnel concerning drug protocol requirements and the use of tests and rating systems for such protocol; training clinical trial site personnel in the use of medical and research equipment required by drug protocols; providing training in the field of clinical trials and clinical trial management for the medical device, pharmaceutical and biotechnological industries; consultation services in the field of educational training in the field of conducting clinical trials in accordance with client and regulatory authority guidance, laws and expectations, and Good Clinical Practice regulatory mandates and guidelines |
| Goods and Services | Consultation services in the field of medical research and clinical trials in the pharmaceutical, biotechnology and medical device industries; consultation services for medical and scientific research purposes in the field of pharmaceutical and biotechnical investigation and human testing; clinical research program development services in the pharmaceutical, biotechnology and medical device industries; medical and scientific research consulting services, namely, consulting on clinical trials in the fields of pharmaceuticals, biotechnology, and medical devices; accreditation services, namely, developing, evaluating, and testing standards for clinical trials of pharmaceuticals, biotechnology and medical devices for the purpose of accreditation; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, Corrective and Preventive action follow -up and effectiveness verification, in the field of clinical trials, clinical research, medical laboratories, bioanalytical laboratories, and clinical laboratories for pharmaceuticals, biotechnology and medical device companies; providing quality assurance services in the field of pharmaceuticals, biotechnology and medical devices, namely, testing, analysis, and evaluation of clinical testing of pharmaceuticals, biotechnology, and medical devices; testing, analysis and evaluation of clinical testing of pharmaceuticals, biotechnology and medical devices to assure compliance with industry standards and regulations; consultation services in the field of monitoring practices and procedures for scientific research purposes relating to the conduct of clinical laboratories, medical laboratories, bioanalytical laboratories, and clinical trials in accordance with client and regulatory authority guidance, laws and expectations, good clinical and documentation practices; quality assurance services in the fields of medical devices, biotechnology and pharmaceuticals; clinical data management process assessments, namely, maintenance of software; assessment of compliance with protocols, processes and internal controls, namely, testing and evaluation of clinical trials of others to assure compliance with industry standards; assessment of compliance to existing practice guidelines, namely, evaluating clinical trials for accreditation purposes |
| Goods and Services | Regulatory compliance consulting in the field of clinical trials; regulatory compliance consulting as it applies to the medical device, pharmaceutical, and biotechnology industries; tracking and monitoring regulatory requirements in the field of clinical trials, medical laboratories, clinical laboratories and bioanalytical laboratories for regulatory compliance purposes; reviewing standards and practices to assure compliance with clinical trial laws and regulations as applied to the medical device, pharmaceutical and biotechnology industries; regulatory affairs, namely, reviewing standards and practices to assure compliance with clinical trial laws and regulations; regulatory compliance consulting in the field of bioanalytical laboratories; business compliance consultation, namely, regulatory compliance consulting in the field of medical devices, pharmaceuticals, and bioanalytics; assessment of safe medication handling practices in accordance with Investigational New Drug Application federal regulations, namely, regulatory compliance consulting; assessment of compliance with clinical protocols, processes and internal controls, namely, regulatory compliance consulting in the field of clinical trials; assessment of compliance to existing practice guidelines, namely, regulatory compliance consulting in the field of business compliance with country and industry specific regulations in the field of clinical trials |
| Pseudo Mark | CLINICAL QUALITY ASSURANCE |
| International Class | 035 - Advertising; business management; business administration; office functions. |
| US Class Codes | 100, 101, 102 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 19, 2021 |
| Primary Code | 035 |
| First Use Anywhere Date | Thursday, February 1, 2007 |
| First Use In Commerce Date | Thursday, March 1, 2007 |
| International Class | 041 - Education; providing of training; entertainment; sporting and cultural activities. |
| US Class Codes | 100, 101, 107 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 19, 2021 |
| Primary Code | 041 |
| First Use Anywhere Date | Thursday, February 1, 2007 |
| First Use In Commerce Date | Thursday, March 1, 2007 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 19, 2021 |
| Primary Code | 042 |
| First Use Anywhere Date | Thursday, February 1, 2007 |
| First Use In Commerce Date | Thursday, March 1, 2007 |
| International Class | 045 - Legal services; security services for the protection of property and individuals; personal and social services rendered by others to meet the needs of individuals. |
| US Class Codes | 100, 101 |
| Class Status Code | 2 - Sec. 8 - Entire Registration |
| Class Status Date | Friday, March 19, 2021 |
| Primary Code | 045 |
| First Use Anywhere Date | Thursday, February 1, 2007 |
| First Use In Commerce Date | Thursday, March 1, 2007 |
| Party Name | CliniQAl, Inc. |
| Party Type | 30 - Original Registrant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94114 |
| Party Name | CliniQAl, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | San Francisco, CA 94114 |
| Event Date | Event Description |
| Friday, March 19, 2021 | CANCELLED SEC. 8 (6-YR) |
| Monday, August 12, 2019 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED |
| Tuesday, August 12, 2014 | REGISTERED-SUPPLEMENTAL REGISTER |
| Saturday, July 5, 2014 | LAW OFFICE PUBLICATION REVIEW COMPLETED |
| Wednesday, July 2, 2014 | ASSIGNED TO LIE |
| Monday, June 16, 2014 | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER |
| Friday, June 13, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, June 12, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, June 12, 2014 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Monday, May 12, 2014 | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
| Monday, May 12, 2014 | CONTINUATION OF FINAL REFUSAL E-MAILED |
| Monday, May 12, 2014 | ACTION CONTINUING A FINAL - COMPLETED |
| Friday, April 18, 2014 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Thursday, April 17, 2014 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Thursday, April 17, 2014 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Friday, October 18, 2013 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, October 18, 2013 | FINAL REFUSAL E-MAILED |
| Friday, October 18, 2013 | FINAL REFUSAL WRITTEN |
| Tuesday, September 24, 2013 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Monday, September 23, 2013 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Monday, September 23, 2013 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Saturday, March 23, 2013 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Saturday, March 23, 2013 | NON-FINAL ACTION E-MAILED |
| Saturday, March 23, 2013 | NON-FINAL ACTION WRITTEN |
| Saturday, March 23, 2013 | ASSIGNED TO EXAMINER |
| Saturday, December 15, 2012 | NOTICE OF PSEUDO MARK MAILED |
| Friday, December 14, 2012 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
| Saturday, December 8, 2012 | NEW APPLICATION ENTERED IN TRAM |